Opinion
Published on 18 Sep 2024
Achieving synchrony: bridging the gap between pharmaceutical companies and regulators on safety labeling updates
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1477516
- 111 views
Volumes
65 Publications
Volume 4 - 2024
Original Research
Published on 17 Sep 2024
Demonstrating the principal mechanism of action of medical devices intended for vaginal use on reconstructed human vaginal epithelium: the case of two hyaluronic acid-containing devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1445519
- 145 views
Original Research
Published on 16 Aug 2024
Exploring the scientific underpinnings of investigating safety signals: analytical insights in deciphering drug safety evidence
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1445998
- 1,015 views
Original Research
Published on 12 Aug 2024
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group”
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1363086
- 801 views
Original Research
Published on 19 Jul 2024
Measurement error and bias in real-world oncology endpoints when constructing external control arms
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1423493
- 1,666 views
Original Research
Published on 27 Jun 2024
Assessing the performance of large language models in literature screening for pharmacovigilance: a comparative study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1379260
- 949 views
Original Research
Published on 13 May 2024
Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1334468
- 528 views
Methods
Published on 11 Apr 2024
Application of the target trial emulation framework to external comparator studies
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1380568
- 1,646 views
Opinion
Published on 03 Apr 2024
Regulation 2017/745 on medical devices, two major innovations: 1) the physiological action of devices consisting of natural materials such as vegetal matrices; 2) the chemical-physical-mechanical action of devices made of “substances”, which as such are artificial derivatives
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1389406
- 602 views
Original Research
Published on 20 Mar 2024
Machine learning analysis of patients’ perceptions towards generic medication in Greece: a survey-based study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1363794
- 746 views
Review
Published on 18 Mar 2024
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1356405
- 2,162 views
Editorial
Published on 06 Feb 2024
Editorial: Traditional and innovative approaches for signal detection
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1373689
- 642 views
Editorial
Published on 05 Feb 2024
Editorial: Treatment of comorbidities of asthma and its safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1366847
- 622 views
Systematic Review
Published on 31 Jan 2024
Menstrual disorders following COVID-19 vaccination: a review using a systematic search
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1338466
- 3,507 views
- 3 citations
Volume 3 - 2023
Perspective
Published on 02 Feb 2024
External comparators and estimands
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1332040
- 1,180 views
- 2 citations
Review
Published on 26 Jan 2024
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1323057
- 4,631 views
- 16 citations